Casandra
Casandra Test Code LC04540Version 1 (DRAFT)
Performing Lab
Crohn's Disease Prognostic Profile
Also known as: Glycominds, IBDX
Clinical Use
Order TestUse
Prognostic aid for use in the clinical management of patients who have been diagnosed with Crohn's disease.
Special Instructions
None noted.
Limitations
The absence of antibody reactivity, while associated with an increased incidence of a more benign disease course, does not preclude the future development of more complicated disease or the need for surgery. The presence and increasing titer of antibodies have been correlated with more aggressive disease behavior.
Test Details
Methodology
Immunoassay (EIA)
Biomarkers
4 targets
ACCAALCAAMCAASCA
LOINC Codes
Order Codes
- 53598-9
Result Codes
- 47321-5
- 53594-8
- 53596-3
- 53597-1
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Room temperature
Causes for Rejection
Hemolysis; lipemia; heat-treated specimen; gross bacterial contamination
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Related Tests
Other tests from different labs that may be relevant
IBD Precis™
Prometheus Laboratories
Inflammatory Bowel Disease Serology Panel, Serum
Mayo Clinic Lab
Cytoplasmic Neutrophil Antibodies, Inflammatory Bowel Disease Panel, Serum
Mayo Clinic Lab
Inflammatory Bowel Disease Differentiation Panel
Quest Diagnostics
Inflammatory Bowel Disease Differentiation Panel
ARUP Laboratories
Saccharomyces cerevisiae Antibodies (ASCA) (IgA)
Quest Diagnostics
Infliximab Level and Anti‑drug Antibody for IBD
Quest Diagnostics
Saccharomyces cerevisiae Antibodies (ASCA) (IgG)
Quest Diagnostics
Saccharomyces cerevisiae Antibodies, IgG & IgA
ARUP Laboratories
Saccharomyces cerevisiae Antibodies (ASCA) (IgG, IgA)
Quest Diagnostics